logo
'Old' brains increase risk of death, Alzheimer's, study says

'Old' brains increase risk of death, Alzheimer's, study says

UPI10-07-2025
Study results show that having an extremely aged brain nearly triples a person's risk of dying during a roughly 15-year period. Adobe stock/Hea;thDay
July 10 (UPI) -- They say age is all in your mind -- and that might literally be true, a new study reveals.
People with "young" brains -- brains aging more slowly than their actual age -- are much less likely to die or develop Alzheimer's disease than those with "old" brains suffering from accelerated aging, researchers reported Wednesday in the journal Nature Medicine.
Results show that having an extremely aged brain nearly triples a person's risk of dying during a roughly 15-year period.
At the same time, people with extremely youthful brains had a 40% lower risk of early death, researchers found.
In other words, the biological age of the brain plays an outsized role in determining how long a person has left to live, said senior researcher Tony Wyss-Coray, director of the Knight Initiative for Brain Resilience at Stanford Medicine.
"The brain is the gatekeeper of longevity," he said. "If you've got an old brain, you have an increased likelihood of mortality. If you've got a young brain, you're probably going to live longer."
Previous research has shown that a person's body can age from wear-and-tear more rapidly that what is reflected by their birth date. Essentially, a person's biological age can be older than their calendar age.
For this study, researchers analyzed blood samples from nearly 44,500 people 40 to 70 participating in the UK Biobank, a large-scale health research project in the United Kingdom.
Researchers used proteins found in the blood samples to estimate the biological age of 11 distinct organs or organ systems for each person, including the brain.
About 6% to 7% of participants had "extremely youthful" brains, and a similar proportion had "extremely aged" brains.
Overall, researchers found that any organ's biological age increased its likelihood of disease.
For example, an extremely aged heart increased risk of abnormal heart rhythm or heart failure, and aged lungs increased COPD risk.
But the association between an aged brain and Alzheimer's was particularly powerful - more than three times that of a person with a normally aging brain, researchers said.
On the other hand, people with youthful brains had a quarter of the Alzheimer's risk linked to brains that were aging normally, the study found.
In other words, someone with a biologically old brain is about 12 times as likely to be diagnosed with Alzheimer's as a person the same age with a biologically young brain, researchers concluded.
These results could open the door to new medical screenings that could determine people's risk for various diseases based on the biological age of their organs, Wyss-Coray said.
Future research also could figure out whether existing approved drugs might restore organ youth before people develop a disease based on that aging organ, he added.
"This is, ideally, the future of medicine," Wyss-Coray said. "Today, you go to the doctor because something aches, and they take a look to see what's broken. We're trying to shift from sick care to health care and intervene before people get organ-specific disease."
Wyss-Coray plans to commercialize the blood sample test, working with companies to get it on the market within a few years.
"The cost will come down as we focus on fewer key organs, such as the brain, heart and immune system, to get more resolution and stronger links to specific diseases," he said.
More information
The Mayo Clinic has more on biological versus chronological age.
Copyright © 2025 HealthDay. All rights reserved.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

NASA crew readies for ISS mission launch on Thursday
NASA crew readies for ISS mission launch on Thursday

Miami Herald

time11 minutes ago

  • Miami Herald

NASA crew readies for ISS mission launch on Thursday

July 26 (UPI) -- An international crew of four is readying for Thursday's planned launch of a NASA mission to the International Space Station after arriving at the Kennedy Space Center in Florida. Astronauts Zena Cardman and Mike Fincke, Japanese Aerospace Exploration Agency specialist Kimiya Yui and Roscosmos cosmonaut Oleg Platonov will travel from Kennedy Space Center's Launch Complex 39A to the ISS while aboard the SpaceX Crew Dragon Endeavour. Cardman is the mission's leader. The crew landed at Space Florida's Launch and Landing Facility at 1:12 EDT after leaving from Houston on Saturday morning. "We are absolutely joyed to be here at Kennedy Space Center," Cardman said upon the crew's landing. "This is the first moment when it's really starting to feel real," she said. "This is the beginning of a week when things will feel progressively more and more real as we approach our launch." Mission pilot Fincke said the mission gives him another chance to fly aboard a spacecraft named Endeavour. "One of the last times I landed at the [Florida launch and landing facility] was on space shuttle Endeavour," Fincke told media. "Now we get to go on another endeavor - a Dragon Endeavour," he said. The Endeavour name honors the HMS Endeavour, which British Capt. James Cook used to explore and chart the South Pacific from 1768 to 1771. A SpaceX Falcon 9 rocket will deliver the Endeavor into low Earth orbit, which will make the Crew Dragon spacecraft the most flown among SpaceX's fleet. Thursday's launch is scheduled at 12:09 p.m. EDT and would enable the Endeavor to dock at the ISS on Aug. 2 if the launch occurs as planned. The four crew members will join Expedition 73, which already is at the ISS. An Expedition 74 crew is scheduled to replace the Expedition 73 crew while the Crew 11 team is at the ISS. Copyright 2025 UPI News Corporation. All Rights Reserved.

NASA crew readies for ISS mission launch on Thursday
NASA crew readies for ISS mission launch on Thursday

UPI

time42 minutes ago

  • UPI

NASA crew readies for ISS mission launch on Thursday

1 of 5 | NASA Crew 11 Commander Zena Cardman addresses media after arriving at the Kennedy Space Center in Florida on Saturday. Photo by Joe Marino/UPI | License Photo July 26 (UPI) -- An international crew of four is readying for Thursday's planned launch of a NASA mission to the International Space Station after arriving at the Kennedy Space Center in Florida. Astronauts Zena Cardman and Mike Fincke, Japanese Aerospace Exploration Agency specialist Kimiya Yui and Roscosmos cosmonaut Oleg Platonov will travel from Kennedy Space Center's Launch Complex 39A to the ISS while aboard the SpaceX Crew Dragon Endeavour. Cardman is the mission's leader. The crew landed at Space Florida's Launch and Landing Facility at 1:12 EDT after leaving from Houston on Saturday morning. "We are absolutely joyed to be here at Kennedy Space Center," Cardman said upon the crew's landing. "This is the first moment when it's really starting to feel real," she said. "This is the beginning of a week when things will feel progressively more and more real as we approach our launch." Mission pilot Fincke said the mission gives him another chance to fly aboard a spacecraft named Endeavour. "One of the last times I landed at the [Florida launch and landing facility] was on space shuttle Endeavour," Fincke told media. "Now we get to go on another endeavor - a Dragon Endeavour," he said. The Endeavour name honors the HMS Endeavour, which British Capt. James Cook used to explore and chart the South Pacific from 1768 to 1771. A SpaceX Falcon 9 rocket will deliver the Endeavor into low Earth orbit, which will make the Crew Dragon spacecraft the most flown among SpaceX's fleet. Thursday's launch is scheduled at 12:09 p.m. EDT and would enable the Endeavor to dock at the ISS on Aug. 2 if the launch occurs as planned. The four crew members will join Expedition 73, which already is at the ISS. An Expedition 74 crew is scheduled to replace the Expedition 73 crew while the Crew 11 team is at the ISS.

Europe Grants Limited Approval to Eli Lilly's (LLY) Alzheimer's Drug
Europe Grants Limited Approval to Eli Lilly's (LLY) Alzheimer's Drug

Business Insider

timean hour ago

  • Business Insider

Europe Grants Limited Approval to Eli Lilly's (LLY) Alzheimer's Drug

The European Medicines Agency (EMA) has granted limited approval to Eli Lilly's (LLY) new Alzheimer's drug Kisunla, reversing an earlier decision to reject the drug over concerns of brain swelling and bleeding in patients. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. The treatment for early-onset Alzheimer's, which is administered via a monthly infusion, has already been approved in the U.S., United Kingdom (U.K.), Japan and China. In March, the European Medicines Agency human medicines committee rejected the drug, saying there was a risk of 'potentially fatal events' due to brain injuries and bleeding. But now, after re-examining the drug at the request of Eli Lilly, the medicines committee has recommended granting Kisunla marketing authorization for a limited number of patients who do not have a copy, or only have one copy, of the ApoE4 gene that puts them at a greater risk of Alzheimer's disease. Controlled Access The EMA said the treatment should be administered as part of a controlled access program and under the supervision of physicians trained in managing potentially dangerous symptoms. It also mandated measures aimed at mitigating risks, including more stringent rules for stopping treatment, and said that patients administered Kisunla must start with a low dose. 'This positive opinion marks a significant milestone in our efforts to bring (Kisunla) to eligible patients across Europe,' said Patrik Jonsson, President of Eli Lilly International, in a written statement. '(Kisunla) has the potential to make a meaningful difference for people living with early symptomatic Alzheimer's disease.' Is LLY Stock a Buy? The stock of Eli Lilly has a consensus Strong Buy rating among 19 Wall Street analysts. That rating is based on 16 Buy, two Hold, and one Sell recommendations issued in the last 12 months. The average LLY price target of $1,006.80 implies 26.02% upside from current levels.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store